Literature DB >> 14996412

Immunomodulatory effects of yun zhi and danshen capsules in health subjects--a randomized, double-blind, placebo-controlled, crossover study.

C K Wong1, P S Tse, E L Y Wong, P C Leung, K P Fung, C W K Lam.   

Abstract

Immunostimulating polysaccharides extracted from the Chinese medicinal plant Yun Zhi (Coriolus versicolor) have been found to enhance various immunological functions, and Danshen (Salvia miltiorrhiza) to show beneficial effects on the circulatory system. In the present clinical study, we investigated if regular consumption of Yun Zhi and Danshen capsules could improve cellular immunity in healthy subjects. One hundred healthy subjects were recruited to take Yun Zhi (50 mg/kg body weight) plus Danshen (20 mg/kg body weight) or placebo capsules daily for four successive months and, after a 2-month wash-out period, crossover to take placebo or Yun Zhi plus Danshen capsules for four successive months. Flow cytometry was used to assess the lymphocyte subtypes and concentration of T helper (Th) cell cytokines in culture supernatant. Gene expression of cytokines and cytokine receptors of peripheral blood mononuclear cells (PBMC) was analyzed by cDNA expression array. Results showed that regular oral consumption of Yun Zhi-Danshen capsules could significantly elevate PBMC gene expression of interleukin (IL)-2 receptor, increase the percentage and absolute counts of T helper cell and ratio of CD4(+) (T helper)/CD8(+) (T suppressor and cytotoxic T) cell, and significantly enhance the ex vivo production of typical Th1 cytokine interferon-gamma from PBMC activated by phytohemagglutinin and lipopolysaccharide (all p<0.005). Such consumption had no adverse effects on liver and renal functions, and the biochemical bone profile. Therefore, regular consumption of Yun Zhi and Danshen could be beneficial for immunological functions by potential enhancement of cell-mediated immunity in healthy subjects without any adverse effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996412     DOI: 10.1016/j.intimp.2003.12.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

Authors:  L C W Lit; C K Wong; L S Tam; E K M Li; C W K Lam
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

2.  Happy aging.

Authors:  Ping-chung Leung
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

3.  The efficacy of herbal therapy on quality of life in patients with breast cancer: self-control clinical trial.

Authors:  Lai Yi Eliza Wong; Chun Kwok Wong; Ping Chung Leung; Wei Kei Christopher Lam
Journal:  Patient Prefer Adherence       Date:  2010-07-21       Impact factor: 2.711

4.  Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.

Authors:  Yen-Nien Hou; Gary Deng; Jun J Mao
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

5.  Characterisation and bioactivity of protein-bound polysaccharides from submerged-culture fermentation of Coriolus versicolor Wr-74 and ATCC-20545 strains.

Authors:  Jian Cui; Kelvin Kim Tha Goh; Richard Archer; Harjinder Singh
Journal:  J Ind Microbiol Biotechnol       Date:  2007-02-22       Impact factor: 4.258

6.  Efforts to achieve healthy aging.

Authors:  Ping-Chung Leung
Journal:  Integr Med Insights       Date:  2008-10-29

7.  A study on immunomodulatory mechanism of Polysaccharopeptide mediated by TLR4 signaling pathway.

Authors:  Zhixue Wang; Bing Dong; Zifang Feng; Shuang Yu; Yixi Bao
Journal:  BMC Immunol       Date:  2015-06-02       Impact factor: 3.615

Review 8.  Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide.

Authors:  Mohammad H Saleh; Iran Rashedi; Armand Keating
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

Review 9.  Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.